Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Coordinated Lysosomal Expression and Regulation (CLEAR) motif-containing DNA promoters represent a gene network essential for maintaining cellular proteostasis and metabolic health. These promoters contain a conserved 10-base pair sequence (GTCACGTGAC) that serves as the primary binding site for the Transcription Factor EB (TFEB) and other members of the MiT/TFE family (Sardiello et al., 2009). Upon activation, TFEB translocates to the nucleus and binds to these CLEAR motifs to coordinately upregulate genes involved in lysosomal biogenesis, autophagy, and lipid catabolism (Settembre et al., 2011). This regulatory network is a critical therapeutic target for neurodegenerative diseases, such as Alzheimer's and Parkinson's, where enhancing the clearance of misfolded protein aggregates is beneficial (Napolitano & Ballabio, 2016). Conversely, in certain cancers, the CLEAR network is often constitutively active, providing nutrients to tumor cells and promoting survival under stress, which suggests that inhibition may be a viable strategy in oncology (Perera et al., 2015). Current pharmacological approaches focus on small molecules like trehalose or mTOR inhibitors that indirectly modulate the CLEAR network by promoting TFEB nuclear entry (Palmieri et al., 2011).
Modulation of transcription factor activity (primarily TFEB) to regulate the expression of the CLEAR gene network.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coordinated Lysosomal Expression and Regulation (CLEAR) motif-containing DNA promoters (CLEAR network promoters).